Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Coker

Showing results (151-160 of 187) with videos related to

Pageof 19
Sort By:
BMC Nephrology|February 24, 2026
Muscle strength, neuromuscular function, and functional measures across stages of chronic kidney diseaseNicholas A Coker, Michael J Germain, Talat A Ikizler, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
METTL16 promotes taxane resistance in Triple-Negative Breast Cancer through m <sup>6</sup> A-dependent translational upregulation of ABCB1Elise G Holvey-Bates, Jesse A Coker, Daniel J Lindner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2024
CDK9 Inhibition by Dinaciclib Is a Therapeutic Vulnerability in Epithelioid HemangioendotheliomaAjaybabu V Pobbati, Ashley Burtscher, Nandini Rajaram Siva, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 7, 2022
Cancer Treatment During COVID-19: Resilience of Individuals With Advanced Non-Small Cell Lung Cancer Versus Community ControlsNicole A Arrato, Stephen B Lo, Clarence A Coker, et al.
Biochemistry|April 9, 1999
X-ray structure of 5-aminolevulinic acid dehydratase from Escherichia coli complexed with the inhibitor levulinic acid at 2.0 A resolutionP T Erskine, E Norton, J B Cooper, et al.
Nucleic Acids Research|November 30, 2018
canSAR: update to the cancer translational research and drug discovery knowledgebaseElizabeth A Coker, Costas Mitsopoulos, Joesph E Tym, et al.
Experimental Gerontology|October 18, 2017
Tumor necrosis factor-alpha and soluble TNF-alpha receptor responses in young vs. middle-aged males following eccentric exerciseEliott Arroyo, Adam J Wells, Joseph A Gordon, et al.
Molecular Cancer Therapeutics|April 3, 2022
Individualized Prediction of Drug Response and Rational Combination Therapy in NSCLC Using Artificial Intelligence-Enabled Studies of Acute Phosphoproteomic ChangesElizabeth A Coker, Adam Stewart, Bugra Ozer, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 25, 2022
Screening and enrollment of underrepresented ethnocultural and educational populations in the Alzheimer's Disease Neuroimaging Initiative (ADNI)Miriam T Ashford, Rema Raman, Garrett Miller, et al.
Molecular Cancer Therapeutics|July 3, 2019
Differences in Signaling Patterns on PI3K Inhibition Reveal Context Specificity in <i>KRAS</i>-Mutant CancersAdam Stewart, Elizabeth A Coker, Sebastian Pölsterl, et al.
Pageof 19

Showing results (151-160 of 187) with videos related to

Sort By:
Pageof 19
BMC Nephrology|February 24, 2026
Muscle strength, neuromuscular function, and functional measures across stages of chronic kidney diseaseNicholas A Coker, Michael J Germain, Talat A Ikizler, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
METTL16 promotes taxane resistance in Triple-Negative Breast Cancer through m <sup>6</sup> A-dependent translational upregulation of ABCB1Elise G Holvey-Bates, Jesse A Coker, Daniel J Lindner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2024
CDK9 Inhibition by Dinaciclib Is a Therapeutic Vulnerability in Epithelioid HemangioendotheliomaAjaybabu V Pobbati, Ashley Burtscher, Nandini Rajaram Siva, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 7, 2022
Cancer Treatment During COVID-19: Resilience of Individuals With Advanced Non-Small Cell Lung Cancer Versus Community ControlsNicole A Arrato, Stephen B Lo, Clarence A Coker, et al.
Biochemistry|April 9, 1999
X-ray structure of 5-aminolevulinic acid dehydratase from Escherichia coli complexed with the inhibitor levulinic acid at 2.0 A resolutionP T Erskine, E Norton, J B Cooper, et al.
Nucleic Acids Research|November 30, 2018
canSAR: update to the cancer translational research and drug discovery knowledgebaseElizabeth A Coker, Costas Mitsopoulos, Joesph E Tym, et al.
Experimental Gerontology|October 18, 2017
Tumor necrosis factor-alpha and soluble TNF-alpha receptor responses in young vs. middle-aged males following eccentric exerciseEliott Arroyo, Adam J Wells, Joseph A Gordon, et al.
Molecular Cancer Therapeutics|April 3, 2022
Individualized Prediction of Drug Response and Rational Combination Therapy in NSCLC Using Artificial Intelligence-Enabled Studies of Acute Phosphoproteomic ChangesElizabeth A Coker, Adam Stewart, Bugra Ozer, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 25, 2022
Screening and enrollment of underrepresented ethnocultural and educational populations in the Alzheimer's Disease Neuroimaging Initiative (ADNI)Miriam T Ashford, Rema Raman, Garrett Miller, et al.
Molecular Cancer Therapeutics|July 3, 2019
Differences in Signaling Patterns on PI3K Inhibition Reveal Context Specificity in <i>KRAS</i>-Mutant CancersAdam Stewart, Elizabeth A Coker, Sebastian Pölsterl, et al.
Pageof 19